Pathology Clinical Trial
Official title:
Prospective Cohort Study for the Impact of Preoperative Glycemic Control Status Measured by HbA1c Levels on Pathologic Features and Oncological Outcomes in the Patients With Prostate Cancer
Verified date | May 2015 |
Source | Seoul National University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | Korea: Ministry of Food and Drug Safety |
Study type | Observational |
The effect of preoperative glycemic control measured by HbA1c on prostate cancer (PCa)
outcome remains controversial. Thus, the investigators aim to examine the association of
preoperative glycemic control with oncologic outcomes after radical prostatectomy (RP).
The investigators will prospectively collect the relevant data including preoperative HbA1c
in 264 patients of PCa patients undergoing RP. The associations between clinical variables
and risk of adverse pathological features and disease recurrence will be tested using a
multivariate logistic regression and multiple Cox-proportional hazards model, respectively.
Status | Recruiting |
Enrollment | 264 |
Est. completion date | June 2018 |
Est. primary completion date | June 2018 |
Accepts healthy volunteers | No |
Gender | Male |
Age group | 20 Years to 80 Years |
Eligibility |
Inclusion Criteria: - Prostate cancer diagnosed with prostate biopsy - Clinically localized PCa confirmed by prostate MRI and Bone scan - Patients undergoing RP Exclusion Criteria: - Distant metastasis, preoperatively - Preoperative hormone therapy - Preoperative chemotherapy - Radiation therapy - Medications affecting glucose status other than diabetes mellitus |
Observational Model: Cohort, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
Korea, Republic of | Seoul National University Bundang Hospital | Seongnam-si | Kyunggi-do |
Lead Sponsor | Collaborator |
---|---|
Seoul National University Hospital |
Korea, Republic of,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Biochemical recurrence (BCR) | BCR was defined as either two consecutive increases in serum PSA (>0.2 ng/mL) or the administration of adjuvant therapy during the postoperative follow-up period | postoperative up to 3 years | No |
Primary | Pathological Gleason score | Gleason scores of prostate cancer specimen described in final pathological report | within 2 weeks after surgery | No |
Secondary | Pathological TMN stage | within 2 weeks after surgery | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06315595 -
Improvements in Dynamic Contrast-Enhanced MR Angiography and Perfusion
|
||
Withdrawn |
NCT05191017 -
Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC
|
Phase 1/Phase 2 | |
Completed |
NCT00255125 -
Role of Soy Supplementation in Prostate Cancer Development
|
Phase 3 | |
Terminated |
NCT02809690 -
18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancer
|
Phase 1 | |
Completed |
NCT06020287 -
The Robot-Assisted Laparoscopic Radical Prostatectomy Combined Anterior and Posterior Approach
|
||
Recruiting |
NCT03572946 -
Targeted Biopsy or Standard Biopsy for Clinical Significant Prostate Cancer Detection
|
N/A | |
Active, not recruiting |
NCT03344757 -
Health Gatherings - For Your Health After Cancer
|
N/A | |
Recruiting |
NCT05137561 -
Robotic-arm Assisted 68 Ga PSMA PET/CT Guided Prostate Biopsy Versus MR Directed TRUS Guided Prostate Biopsy
|
N/A | |
Recruiting |
NCT04792138 -
Learning MRI and Histology Image Mappings for Cancer Diagnosis and Prognosis.
|
||
Completed |
NCT03702439 -
Prostate Cancer Screening Trial Using Imaging
|
||
Completed |
NCT04852224 -
Strength, Aging, and Memory in Prostate Cancer
|
||
Completed |
NCT01240551 -
F-18 Sodium Fluoride in Prostate Cancer
|
Phase 2 | |
Not yet recruiting |
NCT06430411 -
Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET Study
|
||
Active, not recruiting |
NCT03493945 -
Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1)
|
Phase 1/Phase 2 | |
Completed |
NCT04376008 -
A Prospective Study Of Free-Hand Transperineal Image Fusion Targeted Biopsies Under Local Anesthesia
|
N/A | |
Recruiting |
NCT05252390 -
NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06292897 -
Using Tissue-based Spatial Data to Understand How Obesity-related Tumor Metabolites Fuel Prostate Cancer Progression
|
||
Recruiting |
NCT03819751 -
MRI-targeted Biopsy of the Prostate: Software Versus Visual Registration in the Accuracy of Prostate Cancer Detection
|
N/A | |
Not yet recruiting |
NCT05460312 -
Protein Kinase A in Prostate Cancer Tissue.
|
||
Completed |
NCT00005916 -
PSA-Based Vaccine and Radiotherapy to Treat Localized Prostate Cancer
|
Phase 2 |